The receptor for advanced glycation endproducts (RAGE) and its two dominant ligands S100A8/A9 and high mobility group box protein 1 (HMGB1) have been implicated as regulatory elements promoting tumor progression in hundreds of studies in both human and mouse systems. Here, HMGB1 is linked to neoplasm.